Sage Journals: Discover world-class research

Abstract

We analyzed the current health economics of vascular access (VA) procedures in Japan. Results showed that the yearly VA-related medical expenses were as high as JPY20 billion and accounted for 1.4% of the total healthcare cost for chronic renal failure. The United States Renal Data System (USRDS) statistics showed that in the USA the yearly VA-related medical expenses accounted for 1.2% of the total medical cost for chronic renal failure, indicating that the costs did not differ much between the two countries. Moreover, percutaneous transluminal angioplasty (PTA) accounts for approximately 60% of VA procedures performed in Japan, and this ratio is increasing every year. Due to the aging of society and longer treatment periods, it is thought that PTA will become a significant procedure for the treatment of chronic renal failure in Japan.

Keywords

Economics Vascular access Medical reimbursement fees

Get full access to this article

View all access options for this article.

References

Ministry of Health

Labour and Welfare Homepage (in Japanese). Available at: http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/10/dl/toukei.pdf. Accessed July 17 2015

Japanese Society for Dialysis Therapy.

An overview of regular dialysis treatment in Japan (as of Dec. 31, 2010)

Tokyo

2011

Explanation of Medical reimbursement fees at Tokyo, 2012

Explanation of Medical reimbursement fees at 1988-2012.

The United States Renal Data System (USRDS) Homepage.

Available at: http://www.usrds.org/adr.htm Accessed July 17 2015

Naganuma

Takemoto

Iguchi

Nakatani

Overviews of patients with chronic dialysis in Osaka, as of December 2013.

J Osaka Soc for Dial Ther 2014;32:167–183

The Economic Issue of Vascular Access within the Japanese Medical Reimbursement System

Abstract

Keywords

Get full access to this article

References